Key Takeaways BRKR shares fell 17.5% in a year, underperforming the S&P 500 but slightly beating the industry's decline.Bruker is seeing growth from CALID and Nano segments, fueled by new products and acquisitions.BRKR faces macro challenges as tariffs and reduced U.S. academic funding pressure demand and margins.Bruker Corporation (BRKR) is well-poised to grow in the coming quarters due to the solid prospects of the CALID group. Within Bruker Scientific Instruments (“BSI”) Nano, revenue momentum is strong ...